The results of the Russian non-interventional (observational) data monitoring program PROGNOSTIC for the drug recommendation and prevention of hypovitaminosis and mineral deficiency in pregnant women
Provision of the body of a pregnant is necessary for normal functioning of micronutrients is the most important factor contributing to physiological pregnancy and normal development of a fetus. The purpose of the study lies in the assessment of the effectiveness and safety of vitamin and mineral complex Vitrum Prenatal forte in prevention of hypovitaminosis and mineral deficiency in pregnant women in order to improve maternal and perinatal outcomes. The observational program called PROGNOSTICS was conducted from September 2013 to January 2016 in 33 cities of 7 regions of Russia. Materials and methods. Clinical and laboratory examination of women, the analysis of the state of a newborn at birth and during the early neonatal period. All patients received vitamin-mineral complex (VMC) Vitrum Prenatal forte as one tablet per day orally after breakfast. The drug intake was started by pregnant women from the time of registration and continued until delivery. An average duration period lasted for 32 weeks. Results and conclusions. The regular intake of balanced VMC, and in particular, Vitrum Prenatal forte promotes physiological pregnancy, reduces the risk of anemia and the incidence of other complications of pregnancy, their components contribute to proper growth and development of the fetus, contribute to the birth of healthy offspring. It was confirmed and no possible influence was noted on the development of ICH fetal macrosomia.